本页面由Tiger Trade Technology Pte. Ltd.提供服务

Carisma Therapeutics, Inc.

0.0331
-0.0043-11.50%
成交量:7.31万
成交额:2,545.33
市值:138.51万
市盈率:0.17
高:0.0375
开:0.0374
低:0.0301
收:0.0374
52周最高:1.27
52周最低:0.0301
股本:4,184.51万
流通股本:3,125.58万
量比:1.44
换手率:0.23%
股息:- -
股息率:- -
每股收益(TTM):0.1920
每股收益(LYR):-1.4588
净资产收益率:-362.79%
总资产收益率:33.03%
市净率:-1.60
市盈率(LYR):-0.02

数据加载中...

2025/12/16

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/12/15

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/12/05

重要事件披露

Form 8-K - Current report
2025/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/15

重要事件披露

Form 8-K - Current report
2025/10/09

重要事件披露

Form 8-K - Current report
2025/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities